Consistent with these biological effects, data from a large population-based cohort in Taiwan showed that initiation of GLP-1RAs, compared with insulin, was associated with a significantly lower incidence of HCC (HR = 0.47, 95% CI: 0.360.61) (Yang et al., 2024)
Taking GLP-1 medications (even in small doses), especially when attempting to follow a fasting protocol without guidance, can increase the risk of unwanted side effects, nutrient deficiencies, or metabolic complications if you arent prescribed the proper dose and monitored during your treatment
Won S.J., Cheung See Kit M
MT-1 Aerosol Kit appears in research contexts involving Aerosol delivery research, formulation comparison, research workflow optimization
These agents work by increasing the water contained in stool, which improves stool weight and consistency
Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes